The critical role of technologies in neonatal care
- PMID: 37944264
- DOI: 10.1016/j.earlhumdev.2023.105898
The critical role of technologies in neonatal care
Abstract
Neonatal care has made significant advances in the last few decades. As a result, mortality and morbidity in high-risk infants, such as extremely preterm infants or those infants with birth-related brain injury, has reduced significantly. Many of these advances have been facilitated or delivered through development of medical technologies allowing clinical teams to be better supported with the care they deliver or provide new therapies and diagnostics to improve management. The delivery of neonatal intensive care requires the provision of medical technologies that are easy to use, reliable, accurate and ideally developed for the unique needs of the newborn population. Many technologies have been developed and commercialised following adult trials without ever being studied in neonatal patients despite the unique characteristics of this population. Increasingly, funders and industry are recognising this major challenge which has resulted in initiatives to develop new ideas from concept through to clinical care. This review explores some of the key medical technologies used in neonatal care and the evidence to support their adoption to improve outcomes. A number of devices have yet to realise their full potential and will require further development to optimise and find their ideal target population and clinical benefit. Examples of emerging technologies, which may soon become more widely used, are also discussed. As neonatal care relies more on medical technologies, we need to be aware of the impact on care pathways, especially from a human factors approach, the associated costs and subsequent benefits to patients alongside the supporting evidence.
Keywords: Devices; Intensive care; Monitoring; Neonatal; Newborn; Technology.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest DS is supported by the NIHR: National Institute for Health and Care Research (NIHR) Children and Young People MedTech Co-operative (CYP MedTech). DS has received funding for technology development from the Medical Research Council, NIHR and Action Medical Research, and is a non-executive director of SurePulse Medical who are developing monitoring solutions for neonatal care. ST is funded by the NIHR i4i funding programme on grant NIHR204171/2022. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or of the Department of Health.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
